Diagnostic
Introduction
Infections caused by Neisseria meningitidis (Nm), Streptococcus pneumoniae (Sp) and Haemophilus influenzae (Hi) are responsible for high morbidity and mortality rates among children and adults in many countries each year. 1, 2 Despite effective antimicrobial and supportive therapy, mortality rates among children remain high, with significant long-term sequelae in survivors. Although adequate treatment requires rapid detection and identification of the bacteria, traditional laboratory diagnostic methods such as culture for the identification of bacterial meningitis pathogens may take 36 h or more. Because of the similarity of clinical symptoms among invasive infections caused by Nm, Sp and Hi, physicians must frequently request laboratories to test the clinical sample for these three microorganisms to determine the causative bacteria and decide on the management of the case. Rapid diagnosis of the etiological agent is also important for health surveillance, in cases of invasive disease, to avoid transmission to close contacts. [1] [2] [3] To address this problem, nonculture methods like PCR have become available during the last two decades, providing early and accurate diagnosis of bacterial meningitis. 1, [4] [5] [6] [7] [8] [9] [10] Because of its rapid, sensitive and specific results, PCR is an important tool to improve the diagnostic of such microorganisms. An additional advantage of PCR over conventional laboratory methods is the possibility to detect genomic DNA from clinical samples without the need of previous culture. Recently, the use of a quantitative PCR method called Real Time-PCR, have improved the diagnosis of infectious agents based on molecular methods. [11] [12] [13] [14] [15] [16] [17] However, the higher cost of reagents and equipment could be a possible drawback to the implementation of this method in public laboratories of developing countries. The use of a basic PCR method, can be still more appropriate for diagnostic purposes in low-budget laboratories. A number of different target genes have been used in several PCRbased assays to specifically detect the genomic DNA of these agents. For N. meningitidis nspA, ctrA and crgA, for H. influenzae bexA and P6, and for S. pneumoniae ply and lytA genes have been used as targets. [4] [5] [6] [7] [8] [9] [10] 18, 19 In order to determine the best combination of primers, we have developed a simple multiplex PCR for the simultaneous detection of the three main agents of meningitis worldwide, Nm, Sp, and Hi. The multiplex PCR method here described allows the detection of the three microorganisms in a single-tube reaction, saving time and reagents. Targ et species specific genes used for Nm, Hi, and Sp detection were nspA, P6, and ply respectively. Primers amplifying higher length fragments were chosen for identification because the visualization of bands below 200 bp through electrophoresis may not be clear depending of the agarose gel type and concentration used. Furthermore, we have compared the specificity and sensitivity of our method to other in-house and commercial PCR-based methods previously described for simultaneous or single detection of Nm, Hi, and Sp from clinical samples. 4, 5, [7] [8] [9] [10] 18, 19 
Materials and methods

Bacterial isolates, clinical samples, and culture conditions
We have analyzed a total of 110 strains isolated from clinical samples (N. meningitidis n = 31, H. influenzae n = 29, S. pneumoniae n = 50) which are part of the Bacterial Culture Collection of the INCQS/FIOCRUZ institute. The strains were isolated during the last five years, from clinical samples of cerebrospinal fluid (CSF) and blood. These samples have been collected from culture-confirmed cases of patients with suspected meningitis in Brazilian public hospitals. The isolates were recovered from clinical samples after inoculation in chocolate agar (blood agar base with 5% sterile defribinated rabbit blood at 56 • C) and incubated at 37 • C in a 5% CO 2 environment. The isolated strains were identified as Nm, Hi, or Sp by colony morphology, latex agglutination of specific antisera (Slidex Meningitis -Biomerieux), Gram staining and optochin susceptibility, the latter only for Sp determination. Each species was confirmed by specific PCR tests 8, 18, 19 freeze-dried and incorporated into the culture collection.
We have also analyzed 134 clinical samples (99 CSF and 35 blood) collected from suspected cases of invasive disease. Thirty four (25.3%) of these samples were considered positive for one of the three pathogens targeted in this study by conventional laboratory tests (culture, microscopy, and latex agglutination) and 100 samples were considered negative after conventional laboratory tests, but collected from patients with suspected symptoms or epidemiological link to invasive disease caused by one of the three agents here described. The study has been approved by the local research ethics committee.
Twenty nine reference strains were used as positive controls as follows: 
Extraction and purification of bacterial DNA
Genomic DNA extraction and purification from isolated strains and negative clinical samples was carried out using the DNeasy Blood and Tissue extraction kit (Qiagen) according to manufacturer instructions. Briefly, 200 l of the clinical sample were processed using the above mentioned extraction kit, which allows total purification of bacterial genomic DNA free of contaminants and enzyme inhibitors. Extraction and purification of DNA was achieved using different washing buffers and separation on Anion-Exchange Resin columns by binding of nucleic acids and further elution for final use. Purified DNA were kept at −20 • C for repeated experiments.
Primer design and PCR conditions
Specific sets of primers frequently used for PCR-diagnosis of the three above-mentioned agents were used and compared with the results achieved using the multiplex approach here described ( Table 1 ). For the detection of Nm by PCR, targetgenes ctrA, crgA and nspA were used, for Sp detection two different regions of the target-gene ply were used. Primers ply-894 and ply-974 were described by Corless et al., 11 targeting a specific region of the pneumococcus pneumolysin gene (ply) amplifying a 80 bp amplicon. A new pair of primers was designed to amplify a larger segment of the ply gene. We used the S. pneumoniae pneumolysin gene GenBank access #M17717 sequence as template for primers design. The region amplified was located between positions 555 and 1554 of the ply gene M17717. For Hi detection, target genes P6 and bexA were used (Table 1) . PCR was carried out using the PCR-MasterMix (Promega) DNA amplification kit according to manufacturer specifications with an equimolar mixture of the four primer pairs at 50 pmol/l each for the multiplex approach. PCR was run on an Eppendorf Mastercycler EP thermocycler with 35 cycles of 95 • C for 30 s, 50 • C for 1 min, 72 • C for 1 min and 30 s and a final extension of 72 • C for 10 min. A 10 l sample of the completed reaction mixture was run in a 1% agarose gel stained with ethidium bromide. Amplified products were visualized and photographed under UV light. We have also used a commercial kit for the detection of the three agents targeted in this study, named SPEED-OLIGO BACTERIAL MENINGITIS from Vircell which is a PCR-based method coupled to a dipstick device that enables specific detection of H. influenzae, N. meningitides, and S. pneumoniae in cerebrospinal fluid samples. The reactions were carried out according to the producer instructions.
Purified DNA of three reference strains: Nm ATCC 13090, Hi ATCC 33533, 49247, and Sp ATCC 33400 were diluted to an undetectable level for sensitivity determination. Tenfold serial dilutions ranging from 10 g to 10 fg DNA per l were used in single and multiplex PCR giving a range of different sensitivity according to the specific set of primers used ( Table 2) . Considering a genome size of roughly 2 Mb for Nm, Sp, and Hi and since 1 kb of ds DNA has a molecular mass of 660 kDa, 10 fg of DNA represent five genomes.
The differentiation of capsulated and non-capsulated H. influenzae strains was carried out by the inclusion of bexA and P6 primer sets in a second multiplex assay. The presence of two bands at 343 bp and 273 bp indicated a capsulated Hi strain. With this result an additional PCR is required for serotype determination. The presence of a single band at 273 bp indicates a non-capsulated Hi strain and no further serotype determination was necessary. 
Results
Novel multiplex PCR
The multiplex PCR approach here described is capable to simultaneously detect genomic DNA of the three agents above described. The three primer pairs used for specifically indicate the etiological agent are nspA (Nm), P6 (Hi), and ply (Sp) giving bands with different sizes: 481 bp, 273 bp, and 1000 bp, respectively ( Fig. 1) . When a positive result is achieved for Hi, an additional PCR is carried out in order to determine if the strain is capsulated. For this second PCR round, specific primers for targeting the bexA gene are used. Amplification of a 343 bp DNA fragment, confirms the presence of a capsulated strain which should be further analyzed to determine the serotype. No amplification after the second PCR round, indicates a non-typeable Hi (HiNT) (Fig. 2 ).
Specificity
The specificity of the assay was assessed by testing a panel of non-Nm, Sp, or Hi strains, which included DNAs from nine pathogenic bacteria which may cause invasive disease with symptoms similar to those caused by the three target organisms. No amplification was observed after PCR with any of the microorganisms tested.
Sensitivity
Uniplex and multiplex PCR using the primer sets and the commercial kit here described, showed positive amplification for at least one of the three targets with all the 110 clinical isolates of Nm, Sp, and Hi. For CSF and blood samples, the sensitivity of PCR for detecting bacterial meningitis or septicemia was able to detect bacterial genomic DNA of all the 34 samples previously scored as positive and for additional 12 samples which were scored as negative after conventional laboratory tests giving a total of 46 (34.3%) PCR positive samples (Table 3) . 
Comparison of detection limits of single, multiplex, and commercial PCR methods
We have compared different primer sets for the detection of the three microorganisms on single and multiplexed reactions. PCR was carried out as a single or multiplexed reaction performed with the sets of primers described in Table 1 . For the commercial kit, the reactions were performed only as a single test (uniplex) for each pathogen as recommended by the producer. As it is shown in Table 2 , conventional PCR test using primers targeting genes nspA, 8 ply (this study) and P6 18 were able to detect the lowest DNA dilutions of each specific target (36.8 fg/L, 80 fg/L and 100 fg/L, respectively) both in the uniplex or multiplex approach. The commercial test SPEED OLIGO targeting genes ctrA, lytA, and bexA showed to be less sensitive than the conventional PCR test ( Table 2 ).
Discussion
Conventional PCR is still widely used as a straightforward laboratory test to detect specific DNA of different pathogens such as virus, bacteria, and protozoa from human or animal clinical samples. Several conventional PCR-based tests have been described for single or simultaneous detection of the most frequent bacterial agents causing invasive disease and meningitis in humans, namely N. meningitidis, S. pneumoniae, and H. influenzae. [4] [5] [6] [7] [8] [9] [10] Gene targets vary according to the microbial agent showing similar sensitivity and specificity. There are few commercial tests based on molecular strategies available for the detection of these pathogens. One of these tests is the Oligo Speed here compared to conventional PCR-based methods targeting different genes for each microbial agent. A great concern on this matter lately raised is the intra-strain gene polymorphism found within meningococcal strains as described on a study. 20 False-negative results by real-time PCR were described for the ctrA gene used as a diagnostic target.
Our results show that the combination of specific primers targeting genes nspA, ply, and P6 on a multiplex approach was able to detect at least 10 gene copies of each bacterial agent. Tw o variants of H. influenzae causing either invasive or noninvasive disease have been described. The most common is the capsulated Hi variant whose capsule is classified according to its polysaccharide structure into six different serotypes (a, b, c, d, e and f) which can be detected using PCR. 19 However, this approach fails to identify non-capsulated strains since it is based on the amplification of a genetic capsule structure. The most common virulence factor of Hi strains is the capsule which helps the bacteria to evade the host immune system. Nevertheless, an increasing number of non-typeable strains has been reported causing different forms of disease [21] [22] [23] and the occurrence of these strains associated to invasive and non-invasive disease has been reported as a concern for new vaccines design. 24, 25 van Ketel et al. 18 described an outer membrane protein (P6) which is exclusively found in all H. influenzae strains and it is not related to the presence of the capsule, being suitable to discriminate between capsulated and non-capsulated strains through a simple PCR. Failure to amplify the bexA gene and amplification of the P6 gene indicates a non-capsulated Hi strain. The single use of primers for the detection of the P6 gene would be sufficient for the detection of Hi strains, but this approach alone would not indicate if the strain is non-capsulated, an important information for epidemiologic surveillance after the introduction of the conjugated Hib vaccine. An additional PCR reaction is required targeting the bexA gene to determine if the strain is capsulated and in this case a serotype-specific PCR can be performed for serotype determination as described by Falla et al. 19 The inclusion of an additional PCR with primers targeting the Hi capsular gene bexA is important, since it can differentiate capsulated to non-capsulated Hi strains (NTHi) which has been considered as a potential emerging pathogen in countries where the conjugated vaccine against Hib has been introduced. 21, [24] [25] [26] [27] [28] [29] An additional advantage of the multiplex system here described is that there is no possibility of misinterpretation of the specific bands with primer excess, which is frequently found below 100 bp, since the length of the shortest band is 273 bp for the bexA gene fragment and other bands are located at 343 bp (P6), 481 bp (nspA) and 1000 bp (ply). Other PCRbased methods use real-time PCR primers which may generate short-length amplicons with difficult preview by agarose gel electrophoresis. 7, 10 Sensitivity was assessed using clinical samples (CSF and whole blood) from culture-confirmed cases for one of the three organisms. Sensitivity for Nm, Sp, and Hi was 100% since all positive cases confirmed by culture gave positive PCR result. Furthermore, 12 samples associated to suspected cases were also scored positive by the multiplex PCR approach here described. It is likely that these samples were considered negative due to previous antibiotic treatment. The use of the novel multiplex PCR gave a total of 46 (34.3%) PCR positive samples (Table 3 ). These results showed how sensitive is the test when other phenotypic or epidemiological results indicate that the agent causing disease could be one of those three bacterial pathogens. Problems related to culture and isolation of these bacteria are frequently reported by several laboratories, where a specific and sensitive molecular test is crucial for the rapid and accurate identification of the disease causing agent.
Real-time PCR has been pointed as advantageous over conventional PCR due to its higher sensitivity and faster resolution since the result can be monitored during the run. However, real-time PCR does not appear to offer advantages when used by public laboratories for broad-range PCR testing a large number of samples. In fact, there may be disadvantages, such as need of trained technical staff, controlled environment for assay setups, and higher cost of equipment and reagents. For public or private laboratories that still use conventional PCR to detect such pathogens, the choice for the best multiplex system is crucial to achieve accurate and reliable results. In the present study, we were able to compare several different primers combinations and gene targets recently described by different authors, with a commercial PCR-based test for the detection of the three agents. Our data show that the most sensitive and reliable combination of primers for a multiplex approach include the following targets: nspA gene for N. meningitidis generating a 481 bp amplicon, 8 ply gene for S. pneumoniae generating a 1000 bp amplicon (sequence described in this study), and P6 gene for H. influenzae generating a 273 bp amplicon. 18 For the discrimination between capsulated and non-capsulated strains of H. influenzae, an additional PCR is required, targeting the bexA gene generating a 343 bp amplicon, 19 when a positive amplification of the P6 gene is observed.
We believe that the standardization of conventional PCRbased tests for the detection of the invasive bacterial agents here described could improve, interoperability, reproducibility, and quality among different worldwide laboratories involved in routine clinical analysis.
